HomeMarket NewsEmpowering Women's Health: CVS Health and Walgreens to Provide Mifepristone in Specific...

Empowering Women’s Health: CVS Health and Walgreens to Provide Mifepristone in Specific States

Actionable Trade Ideas

always free

Protesters Holding Signs Abortion Is Hea

Pharmacy juggernauts CVS Health Corp CVS and Walgreens Boots Alliance Inc WBA have unveiled their plans to distribute the abortion pill mifepristone, aligning with FDA regulations issued last year.

In the preceding year, attorneys general in 20 states, primarily of the Republican ilk, cautioned CVS and Walgreens against dispatching abortion pills within their jurisdictions.

Both pharmacy magnates have verified their certification and are poised to introduce mifepristone in stores, commencing with a phased implementation in select states.

Walgreens is gearing up to launch the service in New York, Pennsylvania, Massachusetts, California, and Illinois within the forthcoming week, as reported by the New York Times.

Concurrently, CVS will kick off the dispensation in all its Massachusetts and Rhode Island outlets in the approaching weeks, according to a report by the NYT citing Amy Thibault, a CVS spokeswoman.

The pharmacy behemoths aim to gradually broaden their services to states where abortion is lawful and pharmacy dispensation is sanctioned, encompassing about half of all the states nationwide.

Nonetheless, they will keep a watchful eye on states like Kansas, Montana, and Wyoming, where abortion restrictions are currently suspended due to legal disputes.

Walgreens exercises caution, with Engerman highlighting that they will refrain from dispensing in states with ambiguous laws to safeguard their pharmacists and staff.

Anticipation looms around a Supreme Court ruling expected later this month that could potentially affect the availability of the medication, especially if the decision upholds limitations on mailing mifepristone.

The U.S. Supreme Court is poised to deliberate on the future of mifepristone, a pivotal drug employed in over fifty percent of all abortions conducted within the U.S.

The case centers on the FDA’s backing of mifepristone, with a probable outcome leading the court, which previously ruled 6-3, to reconsider its stance on the matter, possibly in the upcoming year.

In April of the previous year, a U.S. federal appeals court issued a temporary injunction against a decision by a Texas judge to halt the FDA’s approval of the widely utilized abortion drug.

For now, the abortion pill mifepristone will retain its availability in the U.S., albeit with certain restrictions, including the mandate for in-person doctor consultations to procure the drug and its utilization being restricted to the initial seven weeks of pregnancy from the current ten, as ruled by a federal appeals court.

Price Action: CVS stock is currently experiencing a 0.55% decline at $73.96, whereas WBA shares are on the rise by 0.98% at $21.47 upon the latest check on Friday.

Disclaimer: This content was generated partially with the assistance of AI tools and was reviewed and published by Benzinga editors.

Image Via Shutterstock

Swing Trading Ideas and Market Commentary

Need some new swing ideas? Get free weekly swing ideas and market commentary from Jonathan Bernstein here: Swing Trading.

Explore More

Weekly In-Depth Market Analysis and Actionable Trade Ideas

Get institutional-level analysis and trade ideas to take your trading to the next level, sign up for free and become apart of the community.